Diagnosing and Treating Influenza in the Emergency Department
Click to check your cart0
Emergency Medicine Practice
Emergency Medicine Practice Mobile
Emergency Medicine Practice • November 2026 • Volume 28 • Issue 11 • PubMed:  42902612
Diagnosing and Treating Influenza in the Emergency Department: An Evidence-Based Update

Diagnosing and Treating Influenza in the Emergency Department: An Evidence-Based Update

Infectious Disease CME • Pharmacology CME • Risk Management CME

What ED Clinicians Need to Know

Influenza is one of the most common viral illnesses encountered in the ED, with presentations ranging from mild respiratory symptoms to respiratory failure. Seasonal surges, overlapping respiratory virus circulation, and variation in patient risk make ED management and critical decision-making especially important.

Clinical features overlap with other respiratory illnesses, while older adults and immunocompromised patients may present atypically. This issue reviews common pitfalls in test interpretation, antiviral selection, and recognition of complications, including bacterial superinfection and coinfection with SARS-CoV-2. It also addresses the expanding role of molecular testing and the practical effects of cost, access, and infection control on ED care.

Why This Topic Matters in the ED

  • Seasonal influenza creates a substantial clinical and operational burden, particularly when respiratory viruses cocirculate.
  • Older adults, young children, pregnant and postpartum patients, and immunocompromised patients face greater risks of complications.
  • Test selection and interpretation can affect diagnostic certainty, resource use, treatment decisions, and infection control.
  • Respiratory deterioration, bacterial superinfection, and other complications can change the course of an initially familiar illness.

Clinical Content at a Glance

Clinical Q&A
Why can influenza severity be difficult to assess?
Influenza has a wide spectrum of illness, and its presentation can be atypical in vulnerable patients. The issue reviews clinical features associated with severe disease and complications.
When is influenza testing most useful in the ED?
Testing has the greatest value when it informs care decisions. The review addresses diagnostic stewardship alongside treatment, infection control, and disposition considerations.
How do rapid antigen and molecular tests differ?
The available tests differ in accuracy, turnaround time, cost, and local availability. The issue examines these tradeoffs and common interpretation challenges.
How does patient risk affect antiviral decisions?
Expected benefit and treatment considerations vary with illness severity, patient risk, and symptom duration. The review covers antiviral selection across adult, pediatric, pregnant, and immunocompromised populations.
What complicates the course of influenza?
Bacterial superinfection, respiratory failure, and extrapulmonary complications can contribute to deterioration. The issue also explores coinfection with SARS-CoV-2 and the challenges of distinguishing overlapping illnesses.
Why can influenza severity be difficult to assess?
Influenza has a wide spectrum of illness, and its presentation can be atypical in vulnerable patients. The issue reviews clinical features associated with severe disease and complications.
Case Snapshots

CASE 1 — Influenza in an Older Long-Term Care Resident: An 81-year-old man with heart failure and Alzheimer disease presents with fever, cough, confusion, poor intake, and hypoxemia during an outbreak at his facility; testing detects influenza A. The case highlights assessment of complications and treatment considerations in a vulnerable patient several days into illness.

CASE 2 — Mild Illness and a Request for Antivirals: A healthy 28-year-old schoolteacher presents early in a febrile respiratory illness and requests treatment to help her return to work. The case explores whether testing will change care and how expected benefit, adverse effects, and patient preferences shape treatment discussions.

CASE 3 — Influenza and a Seizure in a Young Child: A 2-year-old boy returns to his baseline mental status after a brief generalized seizure during a febrile respiratory illness, and testing detects influenza B. The case frames the challenges of weighing age-related risk, antiviral treatment, and the appropriate level of ongoing care.

  • CASE 1 — Influenza in an Older Long-Term Care Resident: An 81-year-old man with heart failure and Alzheimer disease presents with fever, cough, confusion, poor intake, and hypoxemia during an outbreak at his facility; testing detects influenza A. The case highlights assessment of complications and treatment considerations in a vulnerable patient several days into illness.
Clinical Tools
  • An overview of the estimated annual US influenza burden and an illustration of influenza virus structure and subtyping.
  • A differential diagnosis summary for influenza-like illness and a comparison of common clinical features in adults and children.
  • A reference covering clinical features associated with severe or complicated influenza.
  • A summary of patient populations at high risk for influenza complications.
  • A comparison of influenza testing methods, including accuracy and time to results.
  • Antiviral medication references for adults and children, including adult renal impairment considerations.
  • A summary of ED disposition considerations across influenza presentations.
  • A clinical pathway for ED management of suspected influenza, integrating patient risk, testing, treatment, and disposition.
  • An overview of the estimated annual US influenza burden and an illustration of influenza virus structure and subtyping.
  • A differential diagnosis summary for influenza-like illness and a comparison of common clinical features in adults and children.
Risk Management Pitfalls
  • Excluding influenza after a negative rapid antigen test.
  • Overlooking atypical presentations without fever.
  • Applying the symptom-duration cutoff rigidly to high-risk patients.
  • Dismissing deterioration after initial improvement.
  • Choosing an antiviral without considering pregnancy-specific limitations.
  • Excluding influenza after a negative rapid antigen test.
  • Overlooking atypical presentations without fever.
Key References

Following are the most informative references cited in this paper, as determined by the authors.

  1. 3. * Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019;68(6):e1-e47. (Clinical practice guideline) DOI: 10.1093/cid/ciy874
  2. 27. * Merckx J, Wali R, Schiller I, et al. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: a systematic review and meta-analysis. Ann Intern Med. 2017;167(6):394-409. (Systematic review and meta-analysis; 162 studies) DOI: 10.7326/M17-0848
  3. 42. * United States Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Updated March 10, 2026. Accessed October 10, 2026. (Public health guidance)
  4. 44. * United States Centers for Disease Control and Prevention. Overview of influenza testing methods. Updated December 19, 2025. Accessed October 10, 2026. (Public health guidance)
  5. 52. * Brendish NJ, Malachira AK, Armstrong L, et al. Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial. Lancet Respir Med. 2017;5(5):401-411. (Open-label randomized controlled trial; 714 patients) DOI: 10.1016/S2213-2600(17)30120-0
  6. 54. * Chartrand C, Leeflang MMG, Minion J, et al. Accuracy of rapid influenza diagnostic tests: a meta-analysis. Ann Intern Med. 2012;156(7):500-511. (Meta-analysis; 159 studies) DOI: 10.7326/0003-4819-156-7-201204030-00403
  7. 59. * Dobson J, Whitley RJ, Pocock S, et al. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015;385(9979):1729-1737. (Meta-analysis; 9 studies, 4328 patients) DOI: 10.1016/S0140-6736(14)62449-1
  8. 60. * Gao Y, Guyatt G, Uyeki TM, et al. Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials. Lancet. 2024;404(10454):753-763. (Systematic review and meta-analysis; 8 studies, 1424 participants) DOI: 10.1016/S0140-6736(24)01307-2
  9. 61. * Fry AM, Goswami D, Nahar K, et al. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial. Lancet Infect Dis. 2014;14(2):109-118. (Randomized controlled trial; 1190 patients) DOI: 10.1016/S1473-3099(13)70267-6
  10. 64. * Hayden FG, Sugaya N, Hirotsu N, et al. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018;379(10):913-923. (Randomized controlled trial; 1064 patients) DOI: 10.1056/NEJMoa1716197

Following are the most informative references cited in this paper, as determined by the authors.

  1. 3. * Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019;68(6):e1-e47. (Clinical practice guideline) DOI: 10.1093/cid/ciy874
  2. 27. * Merckx J, Wali R, Schiller I, et al. Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: a systematic review and meta-analysis. Ann Intern Med. 2017;167(6):394-409. (Systematic review and meta-analysis; 162 studies) DOI: 10.7326/M17-0848

CME Information

Get A Sample Issue Of Emergency Medicine Practice
Enter your email to get your copy today! Plus receive updates on EB Medicine every month.
Verification Word:
Enter Verification Word: